Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

Comparative effectiveness and safety of nab-paclitaxel plus carboplatin vs gemcitabine plus carboplatin in first-line treatment of advanced squamous cell non-small cell lung cancer in a US community oncology setting

Raja Mudad,1 Manish B Patel,2 Sandra Margunato-Debay,2 David Garofalo,3 Lincy S Lal4 1University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Hollywood, FL, USA; 2Celgene Corporation, Summit, NJ, USA; 3Cardinal Health, Dallas, TX, USA; 4University of Texas School of Pub...

Full description

Bibliographic Details
Main Authors: Mudad R, Patel MB, Margunato-Debay S, Garofalo D, Lal LS
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:Lung Cancer: Targets and Therapy
Subjects:
Chemotherapy
doublet treatment options
electronic medical records
NSCLC
real-world evidence
retrospective analysis
Online Access:https://www.dovepress.com/comparative-effectiveness-and-safety-of-nab-paclitaxel-plus-carboplati-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/comparative-effectiveness-and-safety-of-nab-paclitaxel-plus-carboplati-peer-reviewed-article-LCTT

Similar Items